Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Resmed Inc (NY: RMD )

173.83 -11.03 (-5.97%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,005,122
Open 182.00
Bid (Size) 174.00 (4)
Ask (Size) 189.00 (1)
Prev. Close 184.86
Today's Range 172.19 - 183.40
52wk Range 132.24 - 243.52
Shares Outstanding 146,234,244
Dividend Yield 1.10%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals. 
Via The Motley Fool
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea. 
Via Investor's Business Daily

Performance

YTD
+1.19%
+1.19%
1 Month
-8.97%
-8.97%
3 Month
+1.83%
+1.83%
6 Month
+22.05%
+22.05%
1 Year
-22.01%
-22.01%

More News

Read More
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
Via Benzinga
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
Via Benzinga
Why NYSE:RMD qualifies as a good dividend investing stock.
Via Chartmill
Expert Outlook: ResMed Through The Eyes Of 9 Analysts
Via Benzinga
Peering Into ResMed's Recent Short Interest
Via Benzinga
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
Via Chartmill
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
From ResMed Inc.
Via GlobeNewswire
$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
Via Benzinga
ASX : RMD - Resmed Stock Analysis & Elliott Wave Technical Forecast
Via Talk Markets
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
From ResMed Inc.
Via GlobeNewswire
Uncovering Dividend Opportunities with NYSE:RMD.
Via Chartmill
Cracking The Code: Understanding Analyst Reviews For ResMed
Via Benzinga
Why ResMed Stock Is Jumping Today
Via The Motley Fool
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
From ResMed Inc.
Via GlobeNewswire
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
Via The Motley Fool
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
From ResMed Inc.
Via GlobeNewswire
Recap: ResMed Q2 Earnings
Via Benzinga
MatrixCare Earns Three 2024 Best in KLAS Awards
From MatrixCare
Via GlobeNewswire
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
Via Benzinga
ResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Line
Via Investor's Business Daily
AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
Earnings Scheduled For January 24, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.